Recurrent invasive pulmonary aspergillosis or breakthrough fungal infection in a child after haploidentical hematopoietic stem cell transplantation
Journal Title: OncoReview - Year 2016, Vol 6, Issue 3
Abstract
Invasive fungal infections (IFI) are devastating and life threatening infections affecting especially immunocompromised patients. We report on a case of a 14-year-old boy with myelodysplastic syndrome (MDS), after haploidentical hematopoietic stem cell transplantation, in whom invasive pulmonary aspergillosis (IA) was diagnosed and successfully treated with subsequent (despite the secondary antifungal prophylaxis) IA or breakthrough infection development. Thanks to intensive and broad spectrum antifungal treatment (voriconazole upfront therapy, followed by a combination of voriconazole and micafungin, and eventually by the amphotericin B lipid complex), significant improvement was accomplished.
Authors and Affiliations
Tomasz Ociepa
Keywords
Related Articles
- EP ID EP80366
- DOI -
- Views 226
- Downloads 0
Zespół rozpadu guza
Zespół rozpadu guza jest stanem zagrożenia życia występującym u pacjentów z rozległymi nowotworami, u których pod wpływem chemioterapii bądź samoistnie dochodzi do masywnego rozpadu komórek nowotworowych z uwolnieniem ic...
Novel oral anticoagulants in the treatment of cancer patients
Cancer and its treatment are well-recognized risk factors for venous thromboembolism. The risk of thrombotic complications increases 4–7-fold in cancer patients and coexistence of both pathologies is associated with shor...
Quality of life in oncology and quality of life in course of molecularly targeted therapy in patients diagnosed with metastatic renal-cell carcinoma
Introduction of molecularly targeted agents into clinical practice has led to marked progress in pharmacotherapy of advanced renal cell carcinoma. There have been six drugs of the therapeutic class registered to date. Fu...
Application of echocardiography in oncology – practical remarks
The paper presents the contemporary use of echocardiography in diagnosis of primary and metastatic tumors of the heart as well as in assessment of cardiovascular risk related to medical and interventional oncological the...
Adjuvant imatinib after resection of gastrointestinal stromal tumour - systematic review and meta-analysis
[b]Background:[/b] Adjuvant therapy is recommended for population of patients with high risk of recurrence after resection of gastrointestinal stromal tumour.[b]The aim of the study:[/b] Evaluation of clinical efficacy a...